Skip to content
  • info@BioLifeSolutions.com
  • 1.866.424.6543
  • Toggle search form
  • Toggle shopping cart 0

    Cart

  • Products
    • CryoStor®
      • CryoStor CS10
      • CryoStor CS5
      • CryoStor CS2
      • CryoStor CSB
    • HypoThermosol®
      • HypoThermosol®
      • HypoThermosol for Hair
    • ThawSTAR® Products
      • ThawSTAR CB
      • ThawSTAR CFT2
      • AT6
      • CFT1.5
      • CFT2 Confirmation Vials
      • Warranty and PM
      • IOP Qualification Packet
      • BioT ULT Transporter
      • BioT LN2 Transporter
      • BioT ULT Mobile Workstation
    • BloodStor®
      • BloodStor 100
      • BloodStor 55-5
      • BloodStor 27
    • Cell Thawing Media®
      • 10% Dextran 40 (IN 0.9% NaCl)
      • 10% Dextran 40 (IN 5% Dextrose)
    • All Products
  • Resources
    • Certificate of Analysis
    • Blog
    • Events
    • BioPreservation Today
    • White Papers
    • Press Releases
  • Evidence
    • Resource Links
  • Company
    • About
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Quality Management System
    • Distributors
    • Current Job Openings
  • Investors
    • Investors Home
    • Governance
    • Press Releases
    • Financials
    • Stock Information
    • Management Team
    • Investor Contact
  • Contact
    • General Inquiries
    • ThawSTAR Inquiries
    • Master File Request
    • SDS Request Form
    • Sample Request
    • evo Support Request
  • Ask the Scientists
  • ORDER
Close navigation
  • Primary Menu
logo

BioLife Solutions

Biopreservation Tools For Cells, Tissues, and Organs

Close search

Search

Search for:
Home/Blog/Tag: “CQA”

Tag: CQA

Long-Term Stability and Differentiation Potential of Cryopreserved cGMP-Compliant Human Induced Pluripotent Stem Cells

Shafa, M., Walsh, T., Panchalingam, K. M., Richardson, T., Menendez, L., Tian, X., Suresh Babu, S., Dadgar, S., Beller, J., Yang, F., Baghbaderani, B. A.  Long-Term Stability and Differentiation Potential of Cryopreserved cGMP-Compliant Human Induced Pluripotent Stem Cells.  International Journal Of Molecular Sciences. 2020; 21(1), 108.  doi: 10.3390/ijms21010108

Read More

Phase 1 studies of central memory–derived CD19 CAR T–cell therapy following autologous HSCT in patients with B-cell NHL

Wang X, Popplewell L, Wagner J, Naranjo A, Blanchard M, Mott M, Norris A, Wong C, Urak R, Chang W, Khaled S, Siddiqi T, Budde L, Xu J, Chang B, Gidwaney N, Thomas S, Cooper L, Riddell S, Brown C, Jensen M, Forman S. Phase 1 studies of central memory–derived CD19 CAR T–cell therapy following…

Read More

Developing an Advanced Therapy Medicinal Product (ATMP) for the treatment of GvHD

Antunes, Santos. Developing an Advanced Therapy Medicinal Product (ATMP) for the treatment of GvHD. Dissertações de Mestrado.

Read More
Search for:

Blog Archives

Signup Area

    Sign Up for Email Updates

    Biolife Logo

    • Products
    • Company
    • Evidence
    • Investors
    • Blog
    • Ask the Scientists
    • Press Releases
    • Contact
    © 2019 BioLifeSolutions Inc.  All Rights Reserved    |    Terms & Conditions    |    Privacy
    • twitter
    • linkedin
    • facebook